CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3030% below fair value

$89.35−0.44 (-0.49%)

Close on Nov 13, 2026Market cap $114.28BP/E 10.4Yield 2.98%

Cvs Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cvs Health's price to sales ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.2× to 0.5×, with a median of 0.3×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	0.3×	+0.0
2025	Dec 31, 2025	0.3×	+0.1
2024	Dec 31, 2024	0.2×	−0.1
2023	Dec 29, 2023	0.3×	−0.1
2022	Dec 30, 2022	0.4×	−0.1
2021	Dec 31, 2021	0.5×	+0.1
2020	Dec 31, 2020	0.3×	−0.1
2019	Dec 31, 2019	0.4×	+0.0
2018	Dec 31, 2018	0.4×	−0.0
2017	Dec 29, 2017	0.4×	−0.1
2016	Dec 30, 2016	0.5×	−0.2
2015	Dec 31, 2015	0.7×	−0.1
2014	Dec 31, 2014	0.8×	+0.1
2013	Dec 31, 2013	0.7×	+0.2
2012	Dec 31, 2012	0.5×	−0.0
2011	Dec 30, 2011	0.5×	+0.0
2010	Dec 31, 2010	0.5×	+0.0
2009	Dec 31, 2009	0.5×	–